Candel Therapeutics Inc (CADL)

8.615 -0.14 (-1.54%) USD  |  NASDAQ  |  Dec 23, 16:00
8.70 +0.08 (+0.99%) After-Hours: 18:30
More

Candel Therapeutics Free Cash Flow: -28.69M for Sept. 30, 2024

Free Cash Flow Chart

View Free Cash Flow for CADL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Pfizer Inc 8.227B
AnaptysBio Inc -103.39M
Bristol-Myers Squibb Co 13.80B
Inovio Pharmaceuticals Inc -111.18M
NovaBay Pharmaceuticals Inc -4.812M

Free Cash Flow Related Metrics

Cash from Operations (Quarterly) -6.573M
Cash from Financing (Quarterly) 1.677M
Free Cash Flow Per Share (Quarterly) -0.2053
Free Cash Flow Yield -11.09%